There is apparently an analyst forecasting higher revenue but lower profit for 24 and 25. I haven't been able to ascertain who the analyst is. Any idea who it is and why they might say that? For example, is it an expected failure to pass on continued cost increases? Or something else like lower volumes?Any thoughts would help. Thank you
- Forums
- ASX - By Stock
- CSS
- Ann: FY23 Results Announcement
CSS
clean seas seafood limited
Add to My Watchlist
0.00%
!
13.5¢

Ann: FY23 Results Announcement, page-11
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
13.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $28.28M |
Open | High | Low | Value | Volume |
13.5¢ | 13.5¢ | 13.5¢ | $18.51K | 137.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 4127350 | 13.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
14.0¢ | 6763916 | 25 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 4127350 | 0.135 |
3 | 77222 | 0.130 |
1 | 7200 | 0.125 |
1 | 7500 | 0.120 |
1 | 7826 | 0.115 |
Price($) | Vol. | No. |
---|---|---|
0.140 | 6763916 | 25 |
0.145 | 68473 | 1 |
0.150 | 7500 | 2 |
0.155 | 8000 | 1 |
0.200 | 7760 | 1 |
Last trade - 15.40pm 27/06/2025 (20 minute delay) ? |
Featured News
CSS (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online